Skip to main content

News Archive

News Archive - School of Medicine

Molecular Switch Controlling Immune Suppression May Help Turn Up Immunotherapies

September 19, 2016

Researchers at University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to maximize the effectiveness of anti-cancer immune therapy. The researchers identified a molecular switch that controls immune suppression, opening the possibility to further improving and refining emerging immunotherapies that boost the body’s own abilities to fight diseases ranging from cancer to Alzheimer’s and Crohn’s disease.

Researchers Say to Conquer Cancer You Need to Stop It Before It Becomes Cancer

September 16, 2016

In a Perspective piece published this week in PNAS, cancer researchers from across the country, including faculty at University of California San Diego School of Medicine and Moores Cancer Center, write that a greater emphasis on immune-based prevention should be central to new efforts like the federal Cancer Moonshot program, headed by Vice President Joe Biden.

UC San Diego Among Top 10 Best Public Universities in Nation, According to U.S. News & World Report

September 12, 2016

The University of California San Diego is ranked the 10th best public university in the nation by the U.S. News & World Report Best Colleges guidebook, released today. For more than a decade, the publication has included UC San Diego in its list of the nation’s top 10 public universities.

Six-Day Clinical Trial Finds Integrative Medicine Program Alters Blood Serum

September 9, 2016

In a novel controlled clinical trial, participants in a six-day Ayurvedic-based well-being program that featured a vegetarian diet, meditation, yoga and massages experienced measurable decreases in a set of blood-based metabolites associated with inflammation, cardiovascular disease risk and cholesterol regulation.

10 Cancer Moonshot Blue Ribbon Panel Recommendations Embraced by NCI

September 7, 2016

When 28 distinguished individuals convened earlier this year to help shape the scientific mission at the National Cancer Institute (NCI) of Vice President Joe Biden’s National Cancer Moonshot Initiative, they were given five months to draft guidelines to accelerate cancer research, prevention and care. On Wednesday, the National Cancer Advisory Board approved the Blue Ribbon Panel’s 10 recommendations.

UC San Diego a Prominent Presence at Startups Demo Day in D. C.

September 7, 2016

One of the hundreds of companies hatched by the University of California San Diego has a prominent presence in a national showcase of high-potential startups in the nation’s capital. Curtana Pharmaceuticals plays a big role in the high-visibility Washington, D.C. celebration as a major presenter.

‘Inside Innovation’ Series at UC San Diego Kicks Off with Todd Coleman

September 6, 2016

“Inside Innovation,” a new series of free, public presentations, will feature the latest innovation technologies by UC San Diego, with opportunities for participants to get an inside look at what’s happening in our labs, explore commercialization opportunities, and inquire about licensing.

Promising Drug Leads Identified to Combat Heart Disease

September 5, 2016

Using a unique computational approach to rapidly sample, in millisecond time intervals, proteins in their natural state of gyrating, bobbing, and weaving, a research team from UC San Diego and Monash University in Australia has identified promising drug candidates that may selectively combat heart disease, from arrhythmias to cardiac failure.

Protein Subunit Found to Rescue Afflicted Neurons in Huntington’s Disease

September 5, 2016

Using an experimental co-culture approach in which two different types of neurons from a mouse model of Huntington’s disease (HD) are grown side-by-side, connecting to form critically impacted circuits, researchers at University of California San Diego School of Medicine have identified a subunit of a protein that, when expressed, reverse the mutated gene effects responsible for HD.

Nobel Laureate Roger Tsien Dies, Age 64

August 31, 2016

Roger Tsien, PhD, co-winner of the 2008 Nobel Prize in chemistry and professor of pharmacology, chemistry and biochemistry at University of California San Diego School of Medicine for 27 years, died August 24 in Eugene, Ore. He was 64.
Category navigation with Social links